Simultaneous OTUD3 overexpression and MYL12A knockdown in DLBCL cells led to partial G1/G0 phase arrest, slower proliferation, increased CASP3 activity, and reduced mitochondrial activity versus control (Figs. 5G–N, S5H–M). The gene discussed is OTUD3; the disease is diffuse large B-cell lymphoma.